XML 30 R20.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' EQUITY (Tables)

9 Months Ended

May 31, 2023

Shares Outstanding

Shares of Company common stock outstanding for the three and nine months ended May 31, 2023 and 2022 were as follows:


	Three Months Ended May 31,		Nine Months Ended May 31,
	2023	2022	2023	2022
Common stock outstanding, beginning of period	19,930,623	20,181,784	20,260,070	20,141,521
Common stock repurchased during the period *	(83,356)	—	(492,041)	—
Common stock issued during the period	79,552	52,870	158,790	93,133
Common stock outstanding, end of period	19,926,819	20,234,654	19,926,819	20,234,654

*Common stock repurchased per the ASR Agreement, as discussed in further detail, below.

Schedule of Dividends Payable

Dividends

The Company’s Board of Directors declared cash dividends during the fiscal years 2023 and 2022. The details of dividends paid are in the following tables:


(in thousands, except dividend per share)	Fiscal Year 2023

Record Date	Distribution Date	Number of Shares Outstanding on Record Date	Dividend per Share		Total Amount
10/31/2022	11/07/2022	20,299	$	0.06	$	1,218
1/30/2023	2/06/2023	19,924	$	0.06	1,195
4/24/2023	5/01/2023	19,999	$	0.06	1,200

Total					$	3,613


(in thousands, except dividend per share)	Fiscal Year 2022

Record Date	Distribution Date	Number of Shares Outstanding on Record Date	Dividend per Share		Total Amount
10/25/2021	11/01/2021	20,148	$	0.06	$	1,209
1/31/2022	2/07/2022	20,178	$	0.06	1,211
4/25/2022	5/02/2022	20,207	$	0.06	1,212
7/25/2022	8/01/2022	20,239	$	0.06	1,214
Total					$	4,846

Share-based Payment Arrangement, Option, Activity

The following tables summarize information about stock options:


(in thousands, except per share and weighted-average amounts)
Transactions During The Nine Months Ended May 31, 2023	Number of Options	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life
Outstanding, August 31, 2022	1,245	$	28.61	6.14 years
Granted	450	43.82
Exercised	(157)	12.04
Canceled/Forfeited	(54)	43.00
Outstanding, May 31, 2023	1,484	$	34.44	6.83 years
Vested and Exercisable, May 31, 2023	696	$	23.51	4.74 years
Vested and Expected to Vest, May 31, 2023	1,478	$	34.40	6.82 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the current fiscal year 2023 and fiscal year 2022:


(in thousands, except prices)	Nine Months Ended May 31, 2023			Fiscal Year 2022
Estimated fair value of awards granted	$	9,788		$	4,597
Unvested Forfeiture Rate	0.00		%	1.04		%
Weighted-average grant price	$	43.82		$	42.13
Weighted-average market price	$	43.82		$	42.13
Weighted-average volatility	46.15		%	42.80		%
Weighted-average risk-free rate	4.29		%	1.74		%
Weighted-average dividend yield	0.55		%	0.58		%
Weighted-average expected life	6.59 years			6.59 years

Share-based Payment Arrangement, Option, Exercise Price Range

The exercise prices for the options outstanding at May 31, 2023, ranged from $6.85 to $66.14, and the information relating to these options is as follows:

(in thousands except prices)


Exercise Price				Awards Outstanding				Awards Exercisable
Low		High		Quantity	Weighted -Average Remaining Contractual Life	Weighted-Average Exercise Price		Quantity	Weighted-Average Remaining Contractual Life	Weighted-Average Exercise Price
$	6.85	$	9.77	203	2.21 years	$	8.69	203	2.21 years	$	8.69
$	9.78	$	18.76	155	3.74 years	$	10.11	155	3.74 years	$	10.11
$	18.77	$	33.40	210	5.89 years	$	25.34	146	5.80 years	$	24.57
$	33.41	$	47.63	640	8.92 years	$	42.10	83	7.29 years	$	37.95
$	47.64	$	66.14	276	7.81 years	$	56.34	109	7.53 years	$	58.02
				1,484	6.83 years	$	34.44	696	4.74 years	$	23.51